Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease is a research paper published in Preprints.org (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01DK119762-02
Critical role of NRF2 in globin gene regulation in sickle cell disease mouse models
National Institutes of Health
Grant: 5R01HL149365-04
Development of fetal hemoglobin inducers targeting epigenetic and oxidative stress mechanisms
National Institutes of Health
Grant: 5R01DK139694-03
Heme-induced metabolic stress drives ferroptosis in sickle cell disease
Fields of Study
Keywords
Sustainable Development Goals